BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38485222)

  • 1. Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Wess B; Kohler C; Plaikner A; El-Safadi S; Schwandner T; Meinhold-Heerlein I; Favero G
    Int J Gynecol Cancer; 2024 May; 34(5):675-680. PubMed ID: 38485222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
    Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R
    Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid.
    Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H
    Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Lührs O; Ekdahl L; Geppert B; Lönnerfors C; Persson J
    Gynecol Oncol; 2021 Nov; 163(2):289-293. PubMed ID: 34509298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye.
    Tanaka T; Terai Y; Ashihara K; Tsunetoh S; Akagi H; Yamada T; Ohmichi M
    J Gynecol Oncol; 2017 Mar; 28(2):e13. PubMed ID: 27894166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
    Frumovitz M; Plante M; Lee PS; Sandadi S; Lilja JF; Escobar PF; Gien LT; Urbauer DL; Abu-Rustum NR
    Lancet Oncol; 2018 Oct; 19(10):1394-1403. PubMed ID: 30143441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer.
    Rychlik A; Angeles MA; Migliorelli F; Croce S; Mery E; Martinez A; Ferron G; Guyon F; Querleu D
    Int J Gynecol Cancer; 2020 Mar; 30(3):358-363. PubMed ID: 31911532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.
    Pölcher M; Matz S; Braun M; Brambs C; Beer M; Hamann M
    J Surg Oncol; 2021 Mar; 123(4):1092-1098. PubMed ID: 33333589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
    Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Santoro A; Angelico G; Inzani F; Arciuolo D; Spadola S; Valente M; D'Alessandris N; Piermattei A; Fiorentino V; CIanfrini F; Bizzarri N; Pedone Anchora L; Fagotti A; Scambia G; Zannoni GF
    Int J Gynecol Cancer; 2020 Dec; 30(12):1871-1877. PubMed ID: 33127865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.